share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

MAI Capital Management Sells 424 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Defense World ·  10/01 17:51

MAI Capital Management lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 10.2% during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 3,722 shares of the medical equipment provider's stock after selling 424 shares during the period. MAI Capital Management's holdings in Intuitive Surgical were worth $747,000 at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the company. Investment Partners LTD. boosted its position in shares of Intuitive Surgical by 4.8% during the first quarter. Investment Partners LTD. now owns 768 shares of the medical equipment provider's stock valued at $232,000 after buying an additional 35 shares during the period. Transcend Capital Advisors LLC increased its position in shares of Intuitive Surgical by 4.9% during the first quarter. Transcend Capital Advisors LLC now owns 880 shares of the medical equipment provider's stock worth $265,000 after acquiring an additional 41 shares during the period. BLB&B Advisors LLC boosted its holdings in shares of Intuitive Surgical by 6.9% in the first quarter. BLB&B Advisors LLC now owns 693 shares of the medical equipment provider's stock valued at $209,000 after purchasing an additional 45 shares during the period. Venture Visionary Partners LLC raised its position in Intuitive Surgical by 1.5% during the 1st quarter. Venture Visionary Partners LLC now owns 3,024 shares of the medical equipment provider's stock valued at $912,000 after purchasing an additional 45 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC increased its stake in shares of Intuitive Surgical by 2.0% during the first quarter. Douglass Winthrop Advisors LLC now owns 2,308 shares of the medical equipment provider's stock valued at $696,000 after buying an additional 46 shares during the period. Institutional investors own 82.44% of the company's stock.

Get Intuitive Surgical alerts:

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total value of $1,517,505.00. Following the completion of the transaction, the director now directly owns 11,224 shares in the company, valued at approximately $2,671,760.96. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, EVP Myriam Curet sold 9,000 shares of the business's stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of $225.00, for a total value of $2,025,000.00. Following the completion of the sale, the executive vice president now owns 217 shares of the company's stock, valued at approximately $48,825. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 6,375 shares of the stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the transaction, the director now directly owns 11,224 shares in the company, valued at $2,671,760.96. The disclosure for this sale can be found here. Insiders have sold 101,162 shares of company stock valued at $22,062,916 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $187.44 on Friday. The business's 50-day moving average is $216.24 and its two-hundred day moving average is $230.27. The company has a market capitalization of $66.94 billion, a P/E ratio of 47.69, a P/E/G ratio of 5.36 and a beta of 1.31. Intuitive Surgical, Inc. has a fifty-two week low of $184.94 and a fifty-two week high of $369.69.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last issued its earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 EPS for the quarter, missing analysts' consensus estimates of $1.04 by ($0.19). The company had revenue of $1.52 billion during the quarter, compared to analysts' expectations of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same quarter in the previous year, the company earned $1.42 EPS. Analysts forecast that Intuitive Surgical, Inc. will post 3.76 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on ISRG shares. Evercore ISI cut their price objective on shares of Intuitive Surgical from $210.00 to $175.00 in a report on Friday, July 22nd. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $250.00 to $260.00 and gave the company a "buy" rating in a report on Friday, September 9th. Morgan Stanley decreased their target price on shares of Intuitive Surgical from $300.00 to $225.00 and set an "equal weight" rating for the company in a research report on Friday, July 15th. Raymond James reduced their price target on Intuitive Surgical from $294.00 to $255.00 in a research report on Friday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Intuitive Surgical from $225.00 to $205.00 in a research report on Friday, July 22nd. Six research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $268.00.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

  • Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
  • EV Battery Maker Freyr Set For Major Global Expansion
  • MarketBeat: Week in Review 9/26 – 9/30
  • This Is A Memorable Time To Buy Into Micron Technology
  • Declining Profits Challenge the CarMax Value Proposition
  • How Does Keurig Dr Pepper Compare To Larger Rivals Coke & Pepsi?

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.